Search results
Results from the WOW.Com Content Network
St. Jude Children's Research Hospital is a pediatric treatment and research hospital headquartered in Memphis, Tennessee.Founded by entertainer Danny Thomas in 1962, it is a 501(c)(3) designated nonprofit medical corporation which focuses on children's catastrophic diseases, particularly leukemia and other cancers. [1]
This logo image consists only of simple geometric shapes or text. It does not meet the threshold of originality needed for copyright protection, and is therefore in the public domain . Although it is free of copyright restrictions, this image may still be subject to other restrictions .
St. Jude Medical was founded in 1976 to further develop bi-leaflet artificial heart valves, which were originally created in 1972 at the University of Minnesota. [4] [5] St. Jude Medical's bi-leaflet valve was developed in large part by Dr. Demetre Nicoloff of the University of Minnesota and St. Jude Medical employee Don Hanson.
St. Jude Children's Research Hospital — a children's hospital and medical research institute located in Memphis, Tennessee. Pages in category "St. Jude Children's Research Hospital" The following 18 pages are in this category, out of 18 total.
"The St. Jude Thanks and Giving campaign embodies the true spirit of the holiday season," said Marlo Thomas, National Outreach Director for St. Jude Children's Research Hospital.
Taylor is Scientific Director and Executive Vice President of St. Jude Children's Research Hospital in Memphis, Tennessee. [3] He holds the Edward F. Barry Endowed Chair in Cell and Molecular Biology and also serves as Chair of the Department of Cell and Molecular Biology [4] and Director of the St. Jude Pediatric Translational Neuroscience ...
St. Jude: Beating back the woes St. Jude isn't immune to the CRM market's woes; if anything it's in an even worse position than Boston Scientific. Nearly 52% of the company's total sales came from ...
Another piece of bad news has come out for St. Jude Medical (NYS: STJ) regarding an FDA report on defibrillator lead Durata, bringing shares down 12%. In this video, Motley Fool health-care ...